| scholarly article | Q13442814 |
| P50 | author | Subha V. Raman | Q89703867 |
| P2093 | author name string | David A Reiter | |
| Shana E McCormack | |||
| Vidhya Kumar | |||
| Henry Chang | |||
| Martha Belury | |||
| David P Bradley | |||
| P2860 | cites work | Impaired mitochondrial dynamics and bioenergetics in diabetic skeletal muscle | Q27313507 |
| Targeting myocardial substrate metabolism in heart failure: potential for new therapies | Q27694733 | ||
| Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin | Q27935734 | ||
| Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes | Q28249379 | ||
| Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes | Q29616567 | ||
| Mitochondrial dysfunction in the elderly: possible role in insulin resistance | Q29618783 | ||
| Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome | Q30469947 | ||
| Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction | Q33568831 | ||
| Diminished Superoxide Generation Is Associated With Respiratory Chain Dysfunction and Changes in the Mitochondrial Proteome of Sensory Neurons From Diabetic Rats | Q34448722 | ||
| Mitochondrial dysfunction and insulin resistance: an update | Q34668089 | ||
| Bioenergetics of the calf muscle in Friedreich ataxia patients measured by 31P-MRS before and after treatment with recombinant human erythropoietin | Q34902359 | ||
| Understanding the impact of mitochondrial defects in cardiovascular disease: a review | Q34986414 | ||
| Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. | Q35057592 | ||
| Frataxin activates mitochondrial energy conversion and oxidative phosphorylation | Q35412247 | ||
| Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle | Q35665651 | ||
| The role of mitochondria in the pathogenesis of type 2 diabetes | Q36003367 | ||
| Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia | Q36129202 | ||
| Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice | Q36330856 | ||
| Obesity-related derangements in metabolic regulation | Q36498325 | ||
| Oxidative stress, insulin signaling, and diabetes. | Q36570342 | ||
| Understanding the basics of cardiopulmonary exercise testing. | Q36682231 | ||
| Reduced muscle oxidative capacity is independent of O2 availability in elderly people | Q36993426 | ||
| Role of intramyocelluar lipids in human health | Q37007425 | ||
| Metabolic syndrome and all-cause and cardiovascular mortality in an Italian elderly population: the Progetto Veneto Anziani (Pro.V.A.) Study | Q37022974 | ||
| Mitochondrial involvement in non-alcoholic steatohepatitis. | Q37025395 | ||
| Phosphocreatine recovery kinetics following low- and high-intensity exercise in human triceps surae and rat posterior hindlimb muscles | Q37086411 | ||
| Role of reactive oxygen species in the pathogenesis of diabetic nephropathy | Q37290627 | ||
| Best strategies for hypertension management in type 2 diabetes and obesity | Q37738728 | ||
| The use of muscle near-infrared spectroscopy in sport, health and medical sciences: recent developments | Q37946847 | ||
| The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging | Q38116297 | ||
| Mitochondrial dysfunction and complications associated with diabetes | Q38163727 | ||
| Quantification of skeletal muscle mitochondrial function by 31P magnetic resonance spectroscopy techniques: a quantitative review. | Q38207738 | ||
| Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation. | Q38219400 | ||
| Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease | Q38250379 | ||
| Mitochondrial complex I subunits are decreased in murine nonalcoholic fatty liver disease: implication of peroxynitrite | Q38345841 | ||
| Molecular insight and pharmacological approaches targeting mitochondrial dynamics in skeletal muscle during obesity | Q38572485 | ||
| Mitochondrial dysfunction in diabetic neuropathy: a series of unfortunate metabolic events. | Q38586903 | ||
| High glucose induces mitochondrial dysfunction and apoptosis in human retinal pigment epithelium cells via promoting SOCS1 and Fas/FasL signaling | Q38809352 | ||
| Excision of Expanded GAA Repeats Alleviates the Molecular Phenotype of Friedreich's Ataxia. | Q39786829 | ||
| Each-step activation of oxidative phosphorylation is necessary to explain muscle metabolic kinetic responses to exercise and recovery in humans | Q40390777 | ||
| Fenton chemistry: an introduction. | Q40980956 | ||
| Reproducibility assessment of metabolic variables characterizing muscle energetics in vivo: A 31P-MRS study. | Q43282173 | ||
| Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study. | Q43737617 | ||
| An overview of randomized trials of rehabilitation with exercise after myocardial infarction | Q44071977 | ||
| Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes | Q44480693 | ||
| Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis | Q44598592 | ||
| Acidosis inhibits oxidative phosphorylation in contracting human skeletal muscle in vivo | Q44599982 | ||
| Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults | Q45027927 | ||
| Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness | Q45242359 | ||
| On-off asymmetries in oxygen consumption kinetics of single Xenopus laevis skeletal muscle fibres suggest higher-order control. | Q46158312 | ||
| Assessment of in vivo skeletal muscle mitochondrial respiratory capacity in humans by near-infrared spectroscopy: a comparison with in situ measurements | Q46713463 | ||
| Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria | Q48047307 | ||
| The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. | Q51478010 | ||
| Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia. | Q51615708 | ||
| Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles. | Q54234886 | ||
| Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes. | Q54328647 | ||
| Bioenergetics: Dissecting the role of creatine kinase | Q58829574 | ||
| A linear model of muscle respiration explains monoexponential phosphocreatine changes | Q68304703 | ||
| High-resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes | Q68393942 | ||
| Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials | Q68453831 | ||
| In vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise | Q72550046 | ||
| 31P MRS measurement of mitochondrial function in skeletal muscle: reliability, force-level sensitivity and relation to whole body maximal oxygen uptake | Q73431773 | ||
| Near infrared muscle spectroscopy in patients with Friedreich's ataxia | Q78059520 | ||
| Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study | Q80235144 | ||
| The metabolic syndrome | Q82681399 | ||
| A comparison of exercise type and intensity on the noninvasive assessment of skeletal muscle mitochondrial function using near-infrared spectroscopy | Q85450533 | ||
| ACR guidance document on MR safe practices: 2013 | Q85945514 | ||
| P433 | issue | 119 | |
| P921 | main subject | phosphorylation | Q242736 |
| P577 | publication date | 2017-01-19 | |
| P1433 | published in | Journal of Visualized Experiments | Q954500 |
| P1476 | title | Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle. |
Search more.